305 filings
Page 2 of 16
4
bv3efsh
8 Dec 23
SAB Biotherapeutics / Eddie Joe Sullivan ownership change
8:00am
SC 13G
kwx239 q5j
4 Dec 23
SAB Biotherapeutics / BIOTECHNOLOGY VALUE FUND L P ownership change
4:33pm
4
eahe6j8tcxv9
30 Nov 23
SAB Biotherapeutics / Michael King ownership change
5:00pm
4
y92w w730qr
30 Nov 23
SAB Biotherapeutics / Samuel J Reich ownership change
8:00am
8-K
mkwi okmp
29 Nov 23
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying
7:40am
EFFECT
dmjq5ggqb6
29 Nov 23
Notice of effectiveness
12:15am
4
37j29g0p
28 Nov 23
SAB Biotherapeutics / John Petry ownership change
4:05pm
4
6v9oqjcgzpbzev ey
28 Nov 23
SAB Biotherapeutics / Andrew Moin ownership change
4:05pm
4
t83jub0u5u4
28 Nov 23
SAB Biotherapeutics / Helen K. Ellias ownership change
4:05pm
CORRESP
8uomccgg
24 Nov 23
Correspondence with SEC
12:00am
8-K
hjkyp9z 6ij
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:45pm
3
folh8s jhiq4r
22 Nov 23
SAB Biotherapeutics / Helen K. Ellias ownership change
4:30pm
8-K
f4b71od3
20 Nov 23
SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors
5:00pm
S-3/A
fqkdgq
20 Nov 23
Shelf registration (amended)
4:45pm
4/A
2dooj3m
15 Nov 23
SAB Biotherapeutics / Andrew Moin ownership change
9:10pm
4/A
oog9vuv20eivn3h
15 Nov 23
SAB Biotherapeutics / John Petry ownership change
4:30pm
4
l885xzmluuw6 h9dpow
14 Nov 23
SAB Biotherapeutics / Andrew Moin ownership change
7:00pm
DEFA14A
771iexdsce64rqfypapp
14 Nov 23
Additional proxy soliciting materials
4:31pm
8-K/A
67kjjg8g4pnf
14 Nov 23
Unregistered Sales of Equity Securities
4:31pm
4
wr1 k9x06h
14 Nov 23
SAB Biotherapeutics / John Petry ownership change
12:00am